COVID-19: Serum Institute gets DCGI nod to manufacture Sputnik V vaccine in India

SII has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia for developing Sputnik V at its licensed Hadapsar facility.